Diphenhydramine hydrochloride
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Nasal Congestion
Conditions
Nasal Congestion
Trial Timeline
Oct 1, 2006 → Nov 1, 2006
NCT ID
NCT00662337About Diphenhydramine hydrochloride
Diphenhydramine hydrochloride is a phase 1 stage product being developed by Johnson & Johnson for Nasal Congestion. The current trial status is completed. This product is registered under clinical trial identifier NCT00662337. Target conditions include Nasal Congestion.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00662337 | Phase 1 | Completed |
Competing Products
20 competing products in Nasal Congestion